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COMPLICATIONS IN PREVIOUSLY IRRADIATED SALVAGE 
MASTECTOMY PATIENTS. Jennifer Chiu, Bruce Haffty, Richard 
Restifo, and Barbara Ward. Section of Surgical Oncology, Department 
of Surgery, Yale University, School of Medicine, New Haven, CT. 
Prior studies show a wide range of complication rates varying from 7 to 
28% in previously irradiated salvage mastectomy patients. In addition, the 
suitability of implant reconstruction versus autologous tissue reconstruction 
has not been shown definitively in these patients. This study retrospectively 
reviewed a group of 1040 patients treated with lumpectomy and radiation 
therapy at Yale prior to 1990, of which we reviewed the charts of 67 patients, 
ages 31-80 (average age 51.5 years) who had a breast cancer recurrence. An 
unmatched control consisted of 25 patients whose primary treatment was 
mastectomy without prior irradiation. 
Of the 67 previously irradiated patients, 57 had salvage mastectomies 
for their recurrences. The complication rate was 47% among this group 
versus 28% in the non-irradiated control group. In both groups, seromas 
were the most common form of wound complication (9/57 and 3/25) 
followed by cellulitis (7/57 and 1/25). Of note, some of the seromas took 
weeks to resolve in the irradiated group. 
Of the patients who had salvage mastectomies, 9 patients (10 breasts) 
underwent a two stage prosthetic reconstruction. The average follow up was 
5.1 years. The mean dose of radiation was 6,070 cGy, and the average interval 
from radiation therapy to placement of the tissue expander was 4.6 years. In 
one patient (10%) the tissue expander extruded. In four reconstructions (40%) 
there was an uneventful course. Two cases (20%) were difficult to expand 
and the final result lacked projection. One patient (10%) developed an 
infection requiring removal of the permanent prosthesis. Two patients (20%) 
developed Baker class III or IV capsular contractures. Overall, in this group of 
patients with implant reconstruction, 60% of the reconstructions resulted in 
either a complication or an unfavorable result. Of four patients who opted 





These results suggest that previously irradiated salvage mastectomy 
patients are at a higher risk for postoperative complications than are non- 
irradiated mastectomy patients. In addition, this study provides evidence that 
there may be fewer complications with immediate TRAM flap reconstruction 
than with immediate tissue expander reconstruction, making it the 




The incidence of breast cancer, the most common cancer in 
North American women, has risen at an annual rate of 1.2% since 
1940. Between 1982 and 1986, the rate of increase was 4% per year. 
Since 1940, breast cancer mortality has also increased, but more 
slowly. In fact, breast cancer mortality has been stable since 1950, 
but this figure masks a 15% increase among women 55 years of age 
and older and a concomitant 15% decrease among those younger than 
55.1 An estimated 183,000 American women were diagnosed with 
breast cancer in 1994, and an estimated 46,300 were predicted to 
die. It is the leading cause of death among American women, aged 
40-55.2 
The disparity between a rapid rise in incidence and a modest 
increase in mortality is not easily explained. Part of the reason may 
be increased registration of the disease and widespread use of 
mammography in recent years. Prior to the 1980's, <15% of women 
had regular screening. Many of the cancers now being diagnosed are 
of the in situ variety, and it is uncertain whether all of these tumors 
would go on to become invasive if left undiagnosed. Another reason 
may be the apparently less aggressive character of many of the 
newer invasive tumors. Finally, improvements in treatment, 
especially in the past 30 years, may have partially counterbalanced 
the increase in incidence.2 
In Connecticut, the incidence of breast cancer has risen steadily 
over past 2 decades, reflecting an aging population, improved 
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Female Breast Cancer Cases Diagnosed 
in Residents of Connecticut During 
the Period 1979-1993 
GRAPH 1: Breast cancer cases in Connecticut: This graph illustrates the sharp 
rise in breast cancer cases over the past two decades. This rise reflects both a n 
aging population as well as earlier diagnosis with better imaging modalities. 
Lead-time bias is evidenced by the recent plateau in breast cancer cases 
beginning in 1990, reflecting a stabilization in the use of screening. 
Incidence rates underestimate the number of women who are 
affected by this disease in one way or another though. For every 
woman who is diagnosed with breast cancer, another five will 
undergo breast biopsy. It is likely that over 20 million American 




Currently the cumulative risk for any American woman 
developing breast cancer is 12%.2 The single most important risk 
factor is age, especially in Western countries. The probability that a 
60-year-old white American woman will develop breast cancer in a 
single year (1 in 420) is fourteen times that of a 30-year-old (1 in 
5900). At least two hereditary patterns can be ascertained, one with 
a familial aggregation associated with a modest increase in risk and 
the other a truly genetic pattern with high penetrance and linkage to 
a specific gene. Although any family history of breast cancer is 
associated with an increase in risk, only a history of breast cancer in 
a first-degree relative (parent, sibling, or child) is associated with 
more than a trivial increase. A woman's relative risk of developing 
breast cancer is 1.8 if only her mother had breast cancer, 2.5 if one 
sister had breast cancer, and 5.6 if both her mother and one sister 
had breast cancer. Genetic breast cancers occur at a younger age, are 
more likely to be bilateral, and appear in multiple family members 
over three or more generations. Specific genes linked to these 
cancers have been identified on chromosome 17 and include the p5 3 
and the BRCA1 gene. The discovery of these genes opens up the 
possibilities of identifying women at high risk for breast cancer, but 
at present genetic screening is inappropriate unless a woman has a 
pedigree highly suggestive of genetic breast cancer. 
A woman with a history of breast cancer, whether in situ or 
invasive, has an increased risk of approximately 0.5-1% per year of 
developing a new breast cancer in any remaining breast tissue. This 
risk is not entirely proportional to the amount of breast tissue 
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removed. Fortunately, two breast cancers, whether concomitant or 
sequential, do not impart a worse prognosis than one breast cancer. 
Some types of benign breast disease carry an increased risk of 
breast cancer. For example, atypical hyperplasia has a relative risk 
for breast cancer of 4.4. Other risk factors for breast cancer include 
endogenous endocrine factors such as longer intervals from 
menarche to the first full-term pregnancy and from menarche to 
cessation of menses. Women whose menarche begins at age 12 or 
earlier have twice the risk of developing breast cancer as those 
whose menarche begins after age 13. Women who have a natural 
menopause after age 55 are at twice the risk of developing breast 
cancer as those with a natural menopause prior to age 44. The 
increased risk associated with the use of estrogen replacement 
therapy (ERT) in postmenopausal women or oral contraceptives in 
premenopausal women is either very small or nonexistent. However, 
prolonged use of these therapies may result in a modest increase. I n 
a meta-analysis of ERT studies, the relative risk of developing breast 
cancer was 1.3 among women taking ERT for >15 years.5 The risk 
seems to be somewhat greater if estradiol, rather than conjugated 
estrogens, is used and if ERT is begun during the menopausal years. 
The use of progestins with ERT does not decrease, and may even 
augment, the risk of developing breast cancer. A meta-analysis of 
oral contraceptive studies failed to demonstrate any association 
between oral contraceptive use and overall risk of developing breast 
cancer, but prolonged use, especially prior to the first full-term 
pregnancy, was associated with an increased risk of developing 




contraceptive use for >10 years was 1.46 (P=.001) and the relative 
risk from oral contraceptive use for 4 years prior to the first full- 
term pregnancy was 1.72.2 
There are large regional differences in the incidence of breast 
cancer. In the San Francisco bay area, the annual incidence among 
whites is 87 per 100,000 in contrast to only 18.6 per 100,000 in 
rural Japan. Incidence studies among migrants who move from low- 
to high-incidence areas have demonstrated that the risk of 
developing breast cancer in the migrant population will gradually 
rise to the level of the population in the new locale. This pattern of 
change suggests a role for environmental factors in the etiology of 
breast cancer. Among the environmental factors studied so far, a 
region's total production of dietary fat is most closely associated with 
breast cancer risk.2 
The dietary factor most consistently shown to be associated 
with an increased risk of breast cancer is alcohol intake. A meta¬ 
analysis of epidemiological studies demonstrated that an alcohol 
intake of 6 g/day (about 1/2 drink) may be associated with a 
relative risk of 1.3; and intake of 36 g/day was associated with a 
relative risk of 2.8 
Two of the most striking features of breast cancer are its 
variable behavior in different patients and its relatively slow growth 
rate compared with other tumor types. The median survival of 
patients who decline all forms of treatment is about 2.8 years, but 
the tail of these curves is quite long, with some patients living 15-20 
years. Doubling time of the tumor varies from a few days to >2000 
days (mean 100 days), and most patients with the diagnosis of breast 

cancer will have had the disease for 5-10 years prior to diagnosis. 
Less than one-third of the patients with a diagnosis of breast cancer 
will die of this disease, and the majority of those cured will have 
benefited from local treatment alone. 
With the increased awareness of the psychological impact of a 
mastectomy, conservation of the breast has gained emphasis in the 
management of breast cancer. More extensive surgery, such as the 
Halsted radical mastectomy, has been largely abandoned as multiple 
randomized trials have now demonstrated that the 10-20 year 
survival of patients treated with lumpectomy and radiotherapy is 
equivalent to that achieved with mastectomy or mastectomy plus 
adjuvant radiotherapy. 9 With its relative effectiveness and 
cosmetic and psychological advantages, breast-conserving therapy is 
standard therapy for primary treatment of stage I and II breast 
carcinomas, as recommended by the 1990 National Institutes of 
Health Consensus Development Conference. 10 Conservative therapy 
usually includes breast-conserving surgery and radiation therapy to 
eliminate microscopic foci. There is a 1-2% per year actuarial risk of 
local recurrence following conservative therapy and a long term 
failure rate of 15-20%.! 1 
To control recurrent tumor growth, salvage mastectomy, 
followed by the appropriate systemic therapy, has become a viable, 
effective treatment. Improvements in surgical technique and 
postoperative management have led to a reduction in the morbidity, 
mortality, and recurrence associated with aggressive surgical 
treatment of recurrences. Published series following salvage 
s. 
mastectomy have identified a number of factors that may influence 
the risk of subsequent distant relapse, including disease-free 
interval, 12,13 initial tumor stage, 14 histology of the recurrent 
tumor, 15 and patient age. 16 The 5 year actuarial risk of recurrence 
following salvage mastectomy in one series was 41%, 16 with 
histology influencing risk of recurrence most substantially; 
predominantly invasive tumors were found to be associated with a 
higher risk (5 year 52% crude risk) of relapse than focally invasive 
or non-invasive tumors (0/24 patients with relapse). The five year 
survival of patients in the abovementioned series ranged from 5 3- 
81%. 12-16 The extent of recurrence in the breast was found to be 
associated with the risk of further distant failure in the series b y 
Kurtz et. al.12 and Haffty et. al. 12, while Clarke et. al.18 noted that 
nodal or dermal recurrence was associated with poor overall 
survival. Haffty et. al.19 investigated the prognostic significance of 
DNA flow cytometry of the recurrent tumor and defined a favorable 
group based on DNA ploidy and S-phase fraction. To date, no 
published series has shown a statistically significant improvement in 
subsequent outcome with the administration of chemotherapy or 
hormonal intervention. However, demonstration of such an effect in 
a retrospective analysis is difficult due to the small number of 
patients and the nonrandom application of such therapy. 
While patients who undergo salvage mastectomy after a 
recurrence in the breast following conservative therapy(CT) and 
radiation therapy(RT) are at substantial risk of further relapse, their 
prognosis appears to be better than that of women who have chest 
wall recurrence after initial mastectomy. 59% of those who have a 
. 
recurrence in the breast following CT and RT are disease-free 5 years 
after salvage mastectomy. 16 in contrast, only 30% of patients who 
develop a chest wall recurrence after initial mastectomy are disease- 
free at 5 years.2 0 
Surgery of previously irradiated areas poses problems of 
wound healing secondary to radiation-induced damage. In 1975, 
Robinson^l proposed mechanisms by which radiation-induced 
changes occur: microvascular endarteritis, excessive fibrosis, and 
chromosomal alteration. Following initial ionization, cells are killed 
or severely defunctionalized resulting in a red, dry, braised 
appearance to the skin, the severity of changes being related to the 
source, intensity, and length of time of the radiation dosage. 
Soon after heavy radiation, the skin may show varying degrees 
of necrosis, but usually, within a few days or weeks, it will have 
appeared to have recovered. The superficial and deep changes 
continue to progress, however, because of the inexorable progress of 
the induced endarteritis obliterans. The change in the small blood 
vessels, and even in larger ones, is the primary factor influencing 
later tissue defects. Excessive fibrosis is the second fundamental 
change (scar is notorious for its poor wound healing qualities). The 
third factor is the direct cellular damage with chromosomal 
alteration, which may prevent further cellular replication in a normal 
manner. 
The changes in small blood vessels, scar, and cellular damage 
all contribute to increased wound complications, making surgery of 
radiation-exposed tissue a challenge. The general principles are to 1) 
remove altered tissues to the level of good minute blood supply, and 
14 

2) to provide suitable coverage. The coverage is as good as the blood 
supply that supports it, and because progressive diminution of the 
blood flow in the altered tissues is a fundamental problem, resection 
of an area large enough to obtain margins with a healthy blood 
supply is necessary. Otherwise, progressive postoperative necrosis 
may be expected, with infection and poor wound healing. 
15 

MATERIALS AND METHODS: 
Of 1040 patients treated at Yale Hunter Radiation Therapy 
Center, with a lumpectomy and radiation therapy between 1975 and 
1990, 92 patients had a local ipsilateral recurrence following 
conservative therapy. We reviewed the charts of 67 of these 9 2 
patients. Of the 67 patients, 57 elected to undergo salvage 
mastectomy, and this group became the study population. 
67/92 oatients were followed 
57 Salvage mastectomy 
1 Prednisone therapy 
3 Biopsy only 
4 Wide local excision 
1 Axillary sampling 
1 Hyperthermia therapy 
TABLE 1: Types of therapy employed in the treatment of breast 
cancer recurrence in the studied population of 67 patients. 
43 of the 57 patients had a simple mastectomy, and 14 had a 
modified radical mastectomy. Demographically, the age ranged from 
31-70, with a mean age of 51.5. Mean follow-up after first diagnosis, 
as of 1995, was 12.1 years. Mean survival time was 7.7 years, and 
mean time to breast recurrence was 4.8 years. Patients were treated 
with radiation in the range of 5200-6600 rads. 
We also reviewed the charts of an unmatched control group of 
patients, consisting of 25 patients whose primary treatment was 
mastectomy without prior irradiation. Demographically, the age of 
. 
this group of patient ranged from 32-64 years of age (mean age 
45.5). 
15 patients elected to have reconstruction following the 
salvage surgery. 9 patients (10 breasts) opted for reconstruction 
with a submuscular tissue expander, which was replaced with a 
permanent prosthesis during a second stage. 4 patients chose 
immediate reconstruction with a TRAM flap, and two elected 
postponed reconstruction with a latissimus dorsi flap. The average 
age of the patients undergoing reconstruction was 47.9 years. 5 of 
the 9 patients undergoing implant placement were smokers. The 
mean dose of radiation to these patients was 6,070 cgy. 4 patients 
received chemotherapy following their salvage mastectomy. The 
average interval from completion of the radiation therapy to 
placement of the tissue expander was 4.6 years. 
Capsular contracture complications were evaluated using the 
Baker grading system. Contracture significant enough to require 




Of the 57 patients who had a salvage mastectomy to treat their 
recurrences, the complication rate was 47% among these patients 
versus 28% in the non-irradiated group of 25 patients. 
Complications in Salvage Mastectomy 
Pts vs. Control Group 
Irradiated Non-irradiated 
GRAPH 2: A Comparison of salvage mastectomy patients versus nonirradiated 
control patients: 22/57 salvage mastectomy patients experienced postoperative 
complications versus 7/25 nonirradiated mastectomy patients. 
In both groups, seromas were the most common form of wound 
complication followed by cellulitis. 
< 
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GRAPH 3: Types of complications in salvage mastectomy and primary mastectomy 
patients. 15.8% and 12% of patients in the salvage mastectomy and primary mastectomy 
groups, respectively, had seromas. 12.3% and 4% of patients respectively had cellulitis. 
3.3% and 4% of patients respectively had hematoma formation. 
Types of Complications 
Salvage mast. Mastectomy 
Seroma 9 3 
Cellulitis 7 1 
Hematoma 2 1 
Swelling of the axilla 1 0 
Pleural effusion 1 0 
Arm edema 1 0 
Brachial plexus stress injury 1 1 
Wound debridement/necrosis 0 1 
TABLE 2: Types of complications in salvage mastectomy versus primary 
mastectomy patients: The total number of patients with complications was 22 
and 7 in the two groups. Seromas comprised 40.9% of complications in the 
salvage mastectomy group and 48.9% of complications in the primary 
mastectomy group. Cellulitis comprised 31.8% and 14.3% of complications i n 
the two groups, respectively, and hematoma formation comprised 9.1% and 
14.3% of complications in the two groups respectively. 
1 9 
. 
Outlined below is a further breakdown of complications in patients 
who had salvage mastectomies without reconstruction. Of these 43 patients, 
29 patients had a simple mastectomy, and 14 had a modified radical 
mastectomy. 
SALVAGE MASTECTOMIES WITHOUT RECONSTRUCTION 
43 patients had salvage mastectomy without reconstruction 
20 patients of 43 had complications (46.5%) 
29 simple mastectomies 
Complications: 12 patients of 29 (41.4%) 
No complications 
Diffuse discomfort/pain 
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14 modified radical mastectomies 
Complications: 8 patients of 14 (57.1%) 
No complications 6 
Seroma 4 
Brachial plexus stress injury; 
dyesthesia 1 
Arm edema 1 
Cellulitis 3 
Shoulder discomfort 1 
Hematoma 1 
(loose tissue 1 
dry skin 1) 
TABLE 3: Further breakdown of salvage mastectomy patients (modified versus 
simple mastectomy). 
The 12 patients (13 breasts) who had reconstruction had a higher 
rate of complications than the patients who did not have 
reconstruction. 1 of the 4 patients with immediate TRAM flap 
20 

reconstruction had an area of fat necrosis. In one patient the tissue 
expander extruded 1 month after insertion. In the other 8 patients 
(9 breasts), the mean duration from the placement of the tissue 
expander to placement of the permanent prosthesis was 6 months 
(range-3 to 11 months). The following types of permanent implants 
were placed: two textured saline, and four double lumen (Heyer 
Schulte) implants. 
The average follow up was 5.1 years. In 3 patients (4 breasts) 
the postoperative course was uneventful. In 2 patients there was an 
inability to expand the irradiated tissue adequately, and in both 
instances the final breast reconstruction lacked projection. One 
patient developed an infection that required removal of the 
permanent prosthesis 3 months after placement. This patient went 
on to have a TRAM flap reconstruction 5 months later. Two patients 
developed Baker class III or IV capsular contractures, both of whom 
had subsequent revisions. Of the 8 patients (9 breasts) eventually 
having a permanent prosthesis placed, 4 reconstructions (44.4%) 
required additional surgical revisions aside from the planned 
exchange of the tissue expander to a permanent prosthesis. Reasons 
for reoperation included deformed expansion requiring repositioning 
of the tissue expander in 2 patients, and capsular contracture 
requiring capsulectomy and implant exchange in 2 patients. 
‘ 
- 
Complication Rate in Pts Who Elected 
to Have Immediate Reconstruction 














GRAPH 4: Complication rates in patients who elected to have reconstruction 
versus those without reconstruction: 8 of 15 patients who had reconstruction 
(53.3%) had complications versus a complication rate of 47% in the 
nonirradiated group. 
Reconstruction No Reconstruction 
Of the two patients who elected to have autologous tissue 
reconstruction with a latissimus dorsi flap and implant. One patient 
had an area of partial flap necrosis. Of the 4 patients who had TRAM 




Previously irradiated patients are at a higher risk for 
postoperative complications, in particular seromas and cellulitis (16% 
and 12% respectively, as compared with 12% and 4% in the control 
group.) The literature reports complication rates following salvage 
mastectomy in previously irradiated patients in the range of 7- 
24%.22-24 The complication rate of 47% in the irradiated group and 
29% in the control group in our study is higher than in previously 
reviewed literature, and this may be the result of overzealous 
reporting in our study. In a series by Osborne et. al.,22 oniy a 7% 
complication rate was obtained, a rate that they reported did not 
appear to be different from reported complication rates associated 
with mastectomy in non-irradiated tissue. (Of 46 pts, there was one 
wound infection, one hematoma, and one incidence of flap necrosis.) 
In a series of 25 salvage mastectomy patients by Barr et. al.,23 6 
patients (24%) had wound infection or breakdown, one of whom 
required a split-skin graft to repair the defect due to skin edge 
necrosis. In a third series by Cacujum et. al., 24 25 patients with 
salvage mastectomy were found to have a 15% rate of small wound 
complications, with 3 seromas and 1 delay in wound healing. 
There was only a small difference, in the number of 
complications seen between patients electing modified radical vs. 
simple mastectomy for treatment of recurrence (57.4% vs. 41.1%, 
respectively). There was no increase in frequency of complications 
secondary to damage to lymphatic drainage (e.g. lymphedema or 
23 
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increased infection) in the modified radical versus the simple 
mastectomy patient population. 
Reconstruction in salvage surgery patients resulted in much 
higher rates of complications in the reviewed literature. In one 
series by Hathaway et. al.,25 salvage surgery of 15 patients, 46.7% 
requiring chest wall resection, and all receiving either TRAM, 
latissimus dorsi, or omental flap reconstruction, resulted in a 
complication rate of 60%. This rate was divided into 40% minor 
complications (small wound problems) and 60% major complications 
(life-threatening events or major reoperative events.) Despite the 
complication rate, outcome supported the use of aggressive surgical 
treatment and reconstruction in patients with locally advanced and 
recurrent breast cancer. 
The tissue expander with subsequent permanent implant 
placement has been used often and effectively for breast 
reconstruction. In a two stage reconstructive process, the tissue 
expander is placed to stretch the overlying tissue with the eventual 
goal of placing a permanent gel or silicone implant in its place. 
Previous literature has suggested that there may be difficulty in 
expanding previously irradiated skin and in the placement of 
submuscular implants. In a 1987 study, Dickson and Sharped 
reported only 3 of 10 implant reconstructions in previously 
irradiated patients progressed without complication. In 1995, Evans 
et al27 reported that 4 of 7 implants placed with preoperative 
radiation therapy had complications. The complications included 
rupture, pain, or implant exposure, with removal of three of four 
implants. (1 Surgitex, 1 Becker, 1 saline, and 1 Siltex) Overall, 

complications appeared unrelated to implant type (although 
polyurethane implants may be more resistant to radiotherapy) or the 
interval between implant placement and radiotherapy. Of note 
though, the authors excluded tissue expanders from their study, 
while, at present, in both the radiated and nonradiated patient, tissue 
expanders with or without flaps are performed more commonly than 
implant reconstructions alone. 
Spear and Maxwell^ suggested that two-stage (expander and 
then implant) textured anatomic saline implant reconstructions in 
radiated patients may perform better in a "capsulogenic" (likely to 
have capsular contracture) environment than smooth silicone gel- 
filled implants. There has also been ample evidence in other 
studies^ that there is a lower rate of capsular contracture in saline- 
filled implants as compared with silicone-gel filled ones. Spear and 
Maxwell reported the successful use of two-stage textured saline 
expanders and implants in 10 of 10 patients with preoperative 
radiation where the skin was thought to be relatively healthy, 
stressing the importance in assessing the quality of the soft tissues 
and the extent of radiation damage. 
In the group of patients undergoing staged tissue expander and 
implant reconstructions in our study, a favorable result was achieved 
in only 40% of patients. 60% resulted in either a complication or an 
unfavorable result. These results are consistent with the previously 
mentioned studies of implant placement in irradiated tissue and 
suggest that the scar and fibrosis in the area of the irradiated tissue 
make satisfactory expansion difficult. 
25 

The success of surgery depends highly on the quality of the 
tissue. Reconstruction with autologous tissue is more likely to give 
better cosmetic results and a lower complication rate. In addition, 
reconstruction with the TRAM flap often is more effective than 
reconstruction with the latissimus dorsi flap because more irradiated 
tissue is replaced.28 The TRAM flap has outstanding vascularity as 
well with the hypogastric artery supply to the muscular pedicle. The 
complication rate for TRAM flap reconstruction in our group of 
patients was 25%, (1/4 - fat necrosis.) Of the two latissimus dorsi 
flap and a silicone gel implant reconstructions, one patient had a flap 
loss greater than 10%, resulting in a complication rate of greater than 
50% for this technique. This rate of complications in previously 
irradiated autologous tissue reconstruction is consistent with the 
study by Kroll and colleagues^ jn which there was a 39% 
complication rate among previously irradiated patients versus 25% in 
nonirradiated patients. TRAM flap patients had a 33 and 21% 
complication in previously irradiated and non-irradiated patients 
respectively. 63% of latissimus dorsi patients that were previously 
irradiated versus 41% in the nonirradiated group had complications. 
Although our study is consistent with previous evidence that breast 
reconstruction in previously irradiated tissue, even when autologous 
tissue is used for reconstruction, is associated with a higher rate of 
complications, it should be noted that fat necrosis, the complication 
in our study, is more a result of inadequate donor blood supply than 
of the preexisting irradiated tissue. 
Three of the patients in our study underwent prophylactic 
mastectomies on the opposite breast followed by staged 
26 

reconstruction bilaterally, using the same type of implant on both 
breasts. When compared by Dr. Forman^O with the nonirradiated 
side in two patients, the irradiated breast had less projection, and 
was markedly firmer in the third patient (Baker Class III capsular 
contracture). Fodor and Swistel reported on the inability to expand 
fully the implant in a previously irradiated salvage mastectomy 
patient,31 despite supposedly adequate volume within the implant. 
They documented with computed tomography that the tissue 
expander created a bony chest wall deformity due to the unyielding 
nature of the irradiated soft tissue. Both of the patients in our study 
had their implants filled to capacity. Whether there were 
compensatory bony changes in these patients was uncertain. 
No correlation could be made between the type of permanent 
prosthesis and the outcome. In addition there was no trend noted 
between smoking, the time interval from irradiation to placement of 
the tissue expander or postoperative chemotherapy, and the 
eventual result of the implant reconstruction. 
Most patients were irradiated during the mid 1980's and many 
of the implants used are now outdated. With refinements in 
radiation therapy and improved prosthetic devices, greater success 
with implant reconstruction may be possible. 
As noted in previous studies, patients who originally opted for 
breast-sparing treatment with radiation therapy for their initial 
breast cancer, have a large potential for postoperative complications 
following salvage surgery. Consequently, the patient needs to be 
informed of the potential for adverse outcome with salvage 
mastectomy and with either implant or autologous tissue 
27 
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reconstruction. Autologous tissue reconstruction was associated with 
much better cosmetic results and outcome in this study than tissue 
expander-implant reconstruction, making it the recommended 
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